I don’t think it’s possible because yea cost is a factor but it has to make sense. If the study is focused on a disease that predominantly affects that area yes but if it doesn’t I doubt it. My company was working on a drug for a disease common in people from Asian defeat especially Chinese. So they set up a study there but we still had to have CRAs set up, send our scientist here and there and even send samples back and forth.